Skip to content
HowShorted

C4 Therapeutics, Inc. short interest in 2026

In 2026, C4 Therapeutics, Inc.'s disclosed short interest ran from 7.61% of shares outstanding on 15 Jan 2026 to 32.67% on 15 Sep 2026, a change of +25.06 percentage points. The year's high was 32.67% on 15 Sep 2026 and its low 7.35% on 13 Feb 2026, averaging 19.05% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.68 days on 15 Sep 2026. Full history: C4 Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for C4 Therapeutics, Inc. in 2026

2026 in figures

Start of year
7.61% (15 Jan 2026)
End of year
32.67% (15 Sep 2026)
Change
+25.06 pp
High
32.67% (15 Sep 2026)
Low
7.35% (13 Feb 2026)
Average
19.05%
Highest days to cover
22.68 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

C4 Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20267.61%5.79
30 Jan 20267.44%3.84
13 Feb 20267.35%8.19
27 Feb 20268.79%3.4010-K filed, results (8-K)
13 Mar 202613.97%3.74
31 Mar 202616.67%8.42
15 Apr 202621.71%5.05
30 Apr 202621.73%10.88
15 May 202619.22%5.8110-Q filed, results (8-K)
29 May 202619.58%9.43
15 Jun 202620.12%9.52
30 Jun 202622.61%5.25
15 Jul 202621.54%6.65
31 Jul 202624.73%11.12
14 Aug 202627.68%13.9310-Q filed, results (8-K)
31 Aug 202630.41%16.74
15 Sep 202632.67%22.68

See also: C4 Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.